Inventor · disambiguated record
Tobias Schafmeier
Also filed as: SCHAFMEIER TOBIAS
2 granted patents·1 pending application·0 citations·filing 2016–2021
28Inventor score
Files withDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS2HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH1
Top patents by PatentIndex Score
3 records- 0158US11053499B2Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatment of insulin resistanceDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2020·Granted Jul 6, 2021·0 cites·16 claims
- 0248US10676739B2Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatment of insulin resistanceDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2016·Granted Jun 9, 2020·0 cites·18 claims
- 0347US2023330111A1Active agent combination for treatment of cancerHELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tobias Schafmeier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →